We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Regis Corp
RGS
$69.9M
| $2.98M | 0.04% |
8,980
+8,132
| +959% | +$3.08M |
|
|
PRA
452
DELISTED
ProAssurance
PRA
| $2.97M | 0.04% |
82,334
-55,934
| -40% | -$2.08M |
|
453
Tenable Holdings
TENB
$3.56B
| $2.93M | 0.04% |
102,526
+95,716
| +1,406% | +$2.83M |
|
|
ATH
454
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $2.92M | 0.04% |
67,751
-10,000
| -13% | -$432K |
|
455
CenterPoint Energy
CNP
$29.1B
| $2.91M | 0.04% |
101,720
-29,800
| -23% | -$889K |
|
|
ENDP
456
DELISTED
Endo International plc
ENDP
| $2.9M | 0.04% |
703,041
-173,184
| -20% | -$1.09M |
|
457
PepsiCo
PEP
$186B
| $2.88M | 0.04% |
22,000
-11,290
| -34% | -$1.45M |
|
458
Central Pacific Financial
CPF
$997M
| $2.88M | 0.04% |
96,229
| – | – |
|
|
AVID
459
DELISTED
Avid Technology Inc
AVID
| $2.88M | 0.04% |
316,156
-32,229
| -9% | -$263K |
|
460
Allegiant Air
ALGT
$2.64B
| $2.87M | 0.04% |
+20,030
| New | +$2.81M |
|
461
Powell Industries
POWL
$8.46B
| $2.87M | 0.04% |
226,560
+14,346
| +7% | +$160K |
|
|
CUTR
462
DELISTED
Cutera, Inc.
CUTR
| $2.86M | 0.04% |
+137,622
| New | +$2.46M |
|
|
INFN
463
DELISTED
Infinera Corporation Common Stock
INFN
| $2.84M | 0.04% |
975,774
+43,194
| +5% | +$162K |
|
|
BCOV
464
DELISTED
Brightcove, Inc.
BCOV
| $2.84M | 0.04% |
274,656
-45,784
| -14% | -$441K |
|
465
Schneider National
SNDR
$6.59B
| $2.83M | 0.04% |
155,291
-16,700
| -10% | -$324K |
|
466
Diamondrock Hospitality Co
DRH
$2.63B
| $2.83M | 0.04% |
273,691
-15,100
| -5% | -$159K |
|
467
PC Connection
CNXN
$2.05B
| $2.82M | 0.04% |
80,612
+17,636
| +28% | +$618K |
|
468
Kulicke & Soffa
KLIC
$5.3B
| $2.81M | 0.04% |
124,544
+1,400
| +1% | +$30.8K |
|
469
Rush Enterprises Class A
RUSHA
$5.95B
| $2.77M | 0.04% |
170,908
-166,331
| -49% | -$2.91M |
|
470
Ducommun
DCO
$2.68B
| $2.76M | 0.04% |
61,227
+11,790
| +24% | +$529K |
|
471
iShares Russell 1000 Growth ETF
IWF
$122B
| $2.75M | 0.04% |
69,840
| – | – |
|
|
EIGI
472
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $2.74M | 0.04% |
571,371
+132,500
| +30% | +$719K |
|
|
JWN
473
DELISTED
Nordstrom
JWN
| $2.68M | 0.04% |
+84,200
| New | +$3.17M |
|
|
TPIC
474
DELISTED
TPI Composites
TPIC
| $2.67M | 0.04% |
108,168
+5,850
| +6% | +$150K |
|
|
CVSA
475
Covista Inc
CVSA
$3.94B
| $2.67M | 0.04% |
59,259
+4,510
| +8% | +$207K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.